The Board of Directors of MAIA Biotechnology, Inc. has authorized a buyback plan on September 28, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 USD | +8.20% | +27.01% | +305.98% |
05-21 | MAIA Biotechnology, Inc. announced a financing transaction | CI |
05-14 | MAIA Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+305.98% | 104M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- MAIA Stock
- News MAIA Biotechnology, Inc.
- MAIA Biotechnology, Inc. authorizes a Buyback Plan.